You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 240 No. 17, October 20, 1978 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (55)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Toxicity of Penicillamine

A Serious Limitation to Therapy in Rheumatoid Arthritis

Paul B. Halverson, MD; Franklin Kozin, MD; Gerson C. Bernhard, MD; Allan L. Goldman, MD

JAMA. 1978;240(17):1870-1871.


Abstract

A retrospective study of penicillamine toxicity in 156 patients yielded a high incidence of toxic reaction (62%), necessitating discontinuation of the drug therapy in 36% of the patients. Of the total group, proteinuria occurred in 14%, hematologic toxic reaction in 11%, mucocutaneous toxic reaction in 28%, and gastrointestinal intolerance in 12%.

(JAMA 240:1870-1871, 1978)



Author Affiliations

From the Department of Medicine, Rheumatology Section, The Medical College of Wisconsin, Milwaukee.


Footnotes

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate: II. Initial Therapy in 33 Neurologically Affected Patients and Follow-up With Zinc Therapy
Brewer et al.
Arch Neurol 1996;53:1017-1025.
ABSTRACT  

Wilson Disease: Clinical Presentation, Treatment, and Survival
Stremmel et al.
ANN INTERN MED 1991;115:720-726.
ABSTRACT  

The Toxicity of D-Penicillamine in Systemic Sclerosis
STEEN et al.
ANN INTERN MED 1986;104:699-705.
ABSTRACT  

Mercury Intoxication Simulating Amyotrophic Lateral Sclerosis
Adams et al.
JAMA 1983;250:642-643.
ABSTRACT  

Fatal Polymyositis in D-Penicillamine-Treated Rheumatoid Arthritis
DOYLE et al.
ANN INTERN MED 1983;98:327-330.
ABSTRACT  

Penicillamine-Induced Pemphigus
Zone et al.
JAMA 1982;247:2705-2707.
ABSTRACT  

Myasthenia Gravis and Penicillamine Therapy of Rheumatoid Arthritis
Bocanegra et al.
JAMA 1980;244:1822-1823.
ABSTRACT  

Proteinuria During Long-term Captopril Therapy
Case et al.
JAMA 1980;244:346-349.
ABSTRACT  

Adverse Effects of D-Penicillamine in Rheumatoid Arthritis
STEIN et al.
ANN INTERN MED 1980;92:24-29.
ABSTRACT  

Toxicity of D-Penicillamine in Rheumatoid Arthritis
O'BRIEN
ANN INTERN MED 1980;92:120-122.
ABSTRACT  

Rheumatology
Ehrlich
JAMA 1979;241:1390-1391.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.